
Lung precision oncology program (lpop) | veterans affairs
- Select a language for the TTS:
- UK English Female
- UK English Male
- US English Female
- US English Male
- Australian Female
- Australian Male
- Language selected: (auto detect) - EN
Play all audios:

GRAIL: REFLECTION: Real World Evidence for Learnings in Early Cancer Detection, a Clinical Practice Learning Program Galleri Screening study for multiple cancers This is a population study
that uses the Galleri blood test to check for the presence of cancer, as well as the type of cancer. This study looks to determine if the Galleri multi-cancer early detection test will
improve general health measures by checking for more than 50 cancers through a simple blood draw. For more information, please contact Lisa Hue, [email protected], Brian Sturgill,
[email protected], ______ MIRATI: Phase 2 Trial of MRTX849 Monotherapy and in Combination With Pembrolizumab in patients with advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation
Treatment study for advances metastatic cancer with KRAS G12C mutation The phase 2 portion of “MIRATI” is a clinical study for patients with locally advanced non-small cell lung cancer that
have the KRAS G12C mutation. The goal of this study is to evaluate safety and efficacy of the investigational MRTX849 monotherapy, in combination with KEYTRUDA, as a potential first-line
treatment for this type of lung cancer. For more information, please contact Juanita Johnson, [email protected], _______ VALOR: Veterans Affairs Lung Cancer Surgery or Stereotactic
Radiotherapy Treatment study for stage 1 cancer Patients with stage I non-small cell lung cancer have been historically treated with surgery whenever they are fit for an operation, but this
is a nationwide study designed to assist future veterans make the best therapy choice for their cancer. The VALOR study compares two curative treatments — either surgery or an alternative
therapy known as stereotactic radiotherapy — in Veterans with stage I cancer to better understand how an individual’s unique characteristics influence long-term outcomes. For more
information, please contact Jalima Quintero, [email protected], _______ NIGHTINGALE: Clinical Utility of Management of Patients with CT and LDCT Identified Pulmonary Nodules Using the
Percepta Nasal Swab Classifier – with Familiarization Screening study for pulmonary nodule biomarkers This study is designed to develop a minimally-invasive test to better determine a
person’s risk for lung cancer. Results may allow doctors to either avoid unnecessary testing for individuals that are considered low risk or expedite testing for high risk Veterans. For
more information, please contact Lisa Hue, [email protected], Brian Sturgill, [email protected], ________ “BAD IS STRONGER THAN GOOD”: Unconventional financial incentives for smoking
cessation Smoking cessation study A study of financial incentives to counter the negative feeling experienced by a Veteran quitting smoking, this study strives to make it easier for a smoker
to quit smoking and improve their mental health. For more information, please contact Lisa Hue, [email protected],